How GSK’s Canada SC hearing unfolded

The Supreme Court of Canada met in January to hear the Canada Revenue Agency's (CRA) appeal and Glaxo­Smith­Kline's (GSK) response in a case about whether the taxpayer paid too much for active pharmaceutical ingredients (API) from a Swiss associated enterprise.